Open Access. Powered by Scholars. Published by Universities.®

Psychiatric and Mental Health Commons

Open Access. Powered by Scholars. Published by Universities.®

Aga Khan University

Cannabis

Articles 1 - 2 of 2

Full-Text Articles in Psychiatric and Mental Health

A Call For Prudent Taxation Of Cannabis Corporates To Fund Mental Health Programmes, Cyprian Mostert, Jasmit Shah, Lukoye Atwoli, Zul Merali, Manasi Kumar Sep 2022

A Call For Prudent Taxation Of Cannabis Corporates To Fund Mental Health Programmes, Cyprian Mostert, Jasmit Shah, Lukoye Atwoli, Zul Merali, Manasi Kumar

Brain and Mind Institute

Cannabis consumption increases the incidence of psychotic disorders, violence, and cognitive impairments [1]. Governments need to implement progressive tax legislation, such as that which requires the cannabis sector to accept responsibility and account for its contribution to the worsening of these mental health conditions in developing countries. Excise taxes are rarely imposed on the cannabis sector [2], despite the lucrative wealth amassed by this industry. For example, current estimates show that the global cannabis sector was valued at $25 billion in 2021 and is projected to reach $176 billion by 2030, driven solely by cannabis inhalation demands [3]. The projected …


Cannabidiol And The Remainder Of The Plant Extract Modulate The Effects Of Δ9-Tetrahydrocannabinol On Fear Memory Reconsolidation, Anthony Murkar, Pam Kent, Christian Cayer, Jon James, Tony Durst, Zul Merali Aug 2019

Cannabidiol And The Remainder Of The Plant Extract Modulate The Effects Of Δ9-Tetrahydrocannabinol On Fear Memory Reconsolidation, Anthony Murkar, Pam Kent, Christian Cayer, Jon James, Tony Durst, Zul Merali

Brain and Mind Institute

Background: Δ9-Tetrahydrocannabinol (THC, a CB1 receptor agonist) and Cannabidiol (CBD, a non-competitive antagonist of endogenous CB1 and CB2 ligands) are two primary components of Cannabis species, and may modulate fear learning in mammals. The CB1 receptor is widely distributed throughout the cortex and some limbic regions typically associated with fear learning. Humans with posttraumatic disorder (PTSD) have widespread upregulation of CB1 receptor density and reduced availability of endogenous cannabinoid anandamide, suggesting a role for the endocannabinoid system in PTSD. Pharmacological blockade of memory reconsolidation following recall of a conditioned response modulates the expression of learned fear and may represent …